Division of Neuroscience, Oregon National Primate Research Center, Oregon Health and Science University, 505 NW 185th Ave, Beaverton, OR, 97006, USA.
Department of Pediatrics, Oregon Health and Science University, Portland, OR, USA.
Clin Epigenetics. 2021 Sep 19;13(1):177. doi: 10.1186/s13148-021-01161-y.
Maternal smoking during pregnancy (MSDP) affects development of multiple organ systems including the placenta, lung, brain, and vasculature. In particular, children exposed to MSDP show lifelong deficits in pulmonary function and increased risk of asthma and wheeze. Our laboratory has previously shown that vitamin C supplementation during pregnancy prevents some of the adverse effects of MSDP on offspring respiratory outcomes. Epigenetic modifications, including DNA methylation (DNAm), are a likely link between in utero exposures and adverse health outcomes, and MSDP has previously been associated with DNAm changes in blood, placenta, and buccal epithelium. Analysis of placental DNAm may reveal critical targets of MSDP and vitamin C relevant to respiratory health outcomes.
DNAm was measured in placentas obtained from 72 smokers enrolled in the VCSIP RCT: NCT03203603 (37 supplemented with vitamin C, 35 with placebo) and 24 never-smokers for reference. Methylation at one CpG, cg20790161, reached Bonferroni significance and was hypomethylated in vitamin C supplemented smokers versus placebo. Analysis of spatially related CpGs identified 93 candidate differentially methylated regions (DMRs) between treatment groups, including loci known to be associated with lung function, oxidative stress, fetal development and growth, and angiogenesis. Overlap of nominally significant differentially methylated CpGs (DMCs) in never-smokers versus placebo with nominally significant DMCs in vitamin C versus placebo identified 9059 candidate "restored CpGs" for association with placental transcript expression and respiratory outcomes. Methylation at 274 restored candidate CpG sites was associated with expression of 259 genes (FDR < 0.05). We further identified candidate CpGs associated with infant lung function (34 CpGs) and composite wheeze (1 CpG) at 12 months of age (FDR < 0.05). Increased methylation in the DIP2C, APOH/PRKCA, and additional candidate gene regions was associated with improved lung function and decreased wheeze in offspring of vitamin C-treated smokers.
Vitamin C supplementation to pregnant smokers ameliorates changes associated with maternal smoking in placental DNA methylation and gene expression in pathways potentially linked to improved placental function and offspring respiratory health. Further work is necessary to validate candidate loci and elucidate the causal pathway between placental methylation changes and outcomes of offspring exposed to MSDP. Clinical trial registration ClinicalTrials.gov, NCT01723696. Registered November 6, 2012. https://clinicaltrials.gov/ct2/show/record/NCT01723696 .
孕妇吸烟(MSDP)会影响包括胎盘、肺、脑和血管在内的多个器官系统的发育。特别是,暴露于 MSDP 的儿童在肺功能方面存在终身缺陷,并增加了哮喘和喘息的风险。我们的实验室之前已经表明,怀孕期间补充维生素 C 可以预防 MSDP 对后代呼吸结果的一些不利影响。表观遗传修饰,包括 DNA 甲基化(DNAm),是宫内暴露与不良健康结果之间的一个可能联系,并且 MSDP 以前与血液、胎盘和口腔上皮中的 DNAm 变化有关。分析胎盘 DNAm 可能揭示与呼吸健康结果相关的 MSDP 和维生素 C 的关键靶标。
对来自 72 名参加 VCSIP RCT 的吸烟者的胎盘进行了 DNAm 测量:NCT03203603(37 名接受维生素 C 补充,35 名接受安慰剂)和 24 名从不吸烟的人作为参考。与安慰剂相比,维生素 C 补充剂组中一个 CpG 位点(cg20790161)的甲基化达到了 Bonferroni 显著性水平,且呈低甲基化状态。对空间相关 CpG 的分析确定了治疗组之间 93 个候选差异甲基化区域(DMR),包括已知与肺功能、氧化应激、胎儿发育和生长以及血管生成相关的基因座。从不吸烟者与安慰剂相比的名义上显著的差异甲基化 CpGs(DMCs)与维生素 C 与安慰剂相比的名义上显著的 DMCs 的重叠,确定了与胎盘转录表达和呼吸结果相关的 9059 个候选“恢复 CpGs”。在 274 个恢复候选 CpG 位点的甲基化与 259 个基因的表达相关(FDR<0.05)。我们还确定了与婴儿肺功能(34 个 CpG)和复合喘息(1 个 CpG)相关的候选 CpGs,这些 CpGs在 12 个月大时的表达(FDR<0.05)。维生素 C 处理的吸烟者的胎儿中 DIP2C、APOH/PRKCA 和其他候选基因区域的甲基化增加与肺功能改善和喘息减少有关。
在胎盘 DNA 甲基化和基因表达方面,向孕妇吸烟补充维生素 C 可以改善与母体吸烟相关的变化,这可能与改善胎盘功能和后代呼吸健康有关。需要进一步的工作来验证候选基因座,并阐明暴露于 MSDP 的后代胎盘甲基化变化与结果之间的因果途径。临床试验注册ClinicalTrials.gov,NCT01723696。2012 年 11 月 6 日注册。https://clinicaltrials.gov/ct2/show/record/NCT01723696。